Investing Ideas
/
Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies

Header cover image

Hong Kong Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Apr 29, 2024

Companies with a Value score of at least 3, ordered by Value score

106 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	1093 CSPC Pharmaceutical Group	HK$6.60	10.0%	-17.3%	HK$78.2b	HK$9.35	PE12.3x	E4.5%	4.2%
	1093 CSPC Pharmaceutical Group	HK$6.60	10.0%	-17.3%	HK$78.2b	HK$9.35	PE12.3x	E4.5%	4.2%
	2616 CStone Pharmaceuticals	HK$0.91	9.6%	-72.6%	HK$1.2b	HK$3.45	PS2.3x	E56.9%	n/a
	3737 Zhongzhi Pharmaceutical Holdings	HK$1.18	-3.3%	4.4%	HK$1.0b	n/a	PE5.8x	n/a	5.1%
	2616 CStone Pharmaceuticals	HK$1.13	-31.5%	n/a	HK$1.4b	HK$3.87	PS2.6x	E34.1%	n/a
	3347 Hangzhou Tigermed Consulting	CN¥34.30	16.5%	-47.3%	CN¥48.2b	CN¥41.98	PE30.5x	E19.5%	1.0%
	1228 CANbridge Pharmaceuticals	HK$0.41	29.7%	-78.0%	HK$176.3m	HK$7.00	PS1.6x	E10.4%	n/a
	9995 RemeGen	HK$27.85	-1.8%	-39.2%	HK$26.8b	HK$42.87	PS11.1x	E54.9%	n/a
	2096 Simcere Pharmaceutical Group	HK$5.40	3.6%	-41.6%	HK$13.9b	HK$8.62	PE18x	E24.4%	3.2%
	9969 InnoCare Pharma	HK$4.51	7.4%	-49.9%	HK$9.2b	HK$9.73	PS9.9x	E23.7%	n/a

Page 5 of 5